ONDCP Seal


Counterdrug Technology Assessment CenterCounterdrug Technology Assessment Center
2000 Counterdrug Research and Development Blueprint Update

Message From the Director

Today, scientists and engineers from many disciplines are assisting the Office of National Drug Control Policy in exploiting advances in science and technology to stem substance abuse and stop the illicit drug trade. The Counterdrug Technology Assessment Center (CTAC) technology development programs support the goals and objectives of the National Drug Control Strategy. This Blueprint Update provides a periodic report on progress achieved this year. The technologies are being developed to advance the capabilities of the medical, academic, scientific and criminal justice communities as they cooperate to solve the drug abuse problem.

CTAC, in consultation with the National Institute on Drug Abuse, is providing the most advanced facilities to the nation's premier teams of medical researchers working on the underlying causes of drug dependence. The goal has been accomplished by providing leading medical research institutions with neuro-imaging facilities, infrastructure, and technology necessary to support their substance abuse research.

Technologies that meet the needs of police officers, narcotics investigation units, and prosecuting attorneys are being pursued, too. These technologies provide improved drug detection, communications, and surveillance devices and methods to share drug crime investigative information. After these technologies are proven at the federal level, they are provided to state and local law enforcement agencies through the continuing Technology Transfer Program.

Technology plays an important role in safeguarding our borders from the flow of illicit drugs. To examine shipments as they enter the country coded aperture and neutron probe technologies are being developed. These advanced nonintrusive inspection technology concepts will, in time, replace the X-ray and gamma ray systems now used to search conveyances and cargo for hidden drugs at ports-of-entry.

Barry R. McCaffrey
Director
Office of National Drug Control Policy